MAIA: MAIA Biotechnology Inc

MAIA新闻

• 12:16 MAIA Biotechnology Completes Enrollment Of Patients For Part C Of Phase 2 Study Of Ateganosine Sequenced With CPI Cemiplimab To Treat Non-Small Cell Lung Cancer
• 21:09 MAIA Biotechnology Files Resale Prospectus For 751,879 Shares Issued Under Clinical Trial Funding Agreement
• 13:18 MAIA Biotechnology Receives Regulatory Approval By The Spanish Agency For Medicines And Medical Devices And Portugal’s National Authority Of Medicines And Health Products To Begin Screening Patients For Its Ongoing Pivotal Phase 3 THIO-104 Clinical...
• 13:18 MAIA生物技术获得西班牙药品和医疗器械管理局以及葡萄牙国家药品和卫生产品管理局的监管批准，开始筛选非小细胞肺癌患者参与正在进行的关键第三期THIO-104临床试验。
• 12:48 MAIA Biotechnology Says Enrollment In Phase 3 THIO-104 Lung Cancer Trial Of Ateganosine Reaches 65, Targets Over 100 By Year-End
• 12:48 MAIA生物技术表示，Ateganosine在第3期THIO-104肺癌试验中的招募已达到65人，目标年底前达到100人。
• 13:06 Microsoft plans to release its next-generation MAIA 300 AI chip in September
• 15:27 Microsoft: Azure Skies, Premium Altitude (NASDAQ:MSFT)
• 11:49 MAIA Biotechnology股价因折价股票发行下跌29%
• 11:48 MAIA Biotechnology shares drop 29% on discounted stock offering
• 13:35 Stan Smith以每股1.224美元购入MAIA生物科技公司价值69,999美元股票
• 13:26 陆雅仪以99999美元购入MAIA Biotechnology (MAIA)股票
• 13:26 Chaouki Steven M以49999美元购买MAIA Biotechnology股票